Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc

Health CarePharmaceuticals and Biotechnology
  • Price (USD)34.59
  • Today's Change0.91 / 2.70%
  • Shares traded308.79k
  • 1 Year change+23.67%
  • Beta1.0393
Data delayed at least 15 minutes, as of Jun 06 2023 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Events & Activity

  • SUPN:NMQ price moved over +1.18% to 33.35
  • SUPN:NMQ trading volume exceeds daily average by +15.46%
  • SUPN:NMQ price rises above 15-day moving average to 34.10 at 11:10 BST

Key statistics

On Tuesday, Supernus Pharmaceuticals Inc (SUPN:NMQ) closed at 34.59, -17.82% below its 52-week high of 42.09, set on Feb 02, 2023.
52-week range
25.80Jun 13 202242.09Feb 02 2023
Short selling activity
Provided by S&P Global Market Intelligence
Previous close34.59
Average volume403.08k
Shares outstanding54.48m
Free float51.57m
P/E (TTM)38.48
Market cap1.88bn USD
EPS (TTM)0.8989
Data delayed at least 15 minutes, as of Jun 06 2023 21:00 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.